Biblio
Export 1210 results:
Author [ Title
Filters: First Letter Of Last Name is R [Clear All Filters]
“Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.
, “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
, “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
, “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
, “Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 3, pp. 893-910, 2019.
, “Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.”, J Alzheimers Dis, vol. 54, no. 3, pp. 891-895, 2016.
, “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
, “Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.”, J Alzheimers Dis, vol. 54, no. 2, pp. 427-43, 2016.
, “Structural Anatomical Investigation of Long-Term Memory Deficit in Behavioral Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1887-1900, 2018.
, “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1283-1294, 2018.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
,